series-a
Stage
1
Investors
About
Kinaset is a biotechnology company developing novel small molecule therapeutics for the treatment of cancer and other diseases, with a lead program targeting a novel kinase in oncology.
Explore Kinaset's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.